APOE and Cognitive impairment: Together, our findings indicate that microstructural signatures of APOE genotype emerge prior to cognitive impairment in patterns that may differ by sex, with entorhinal neurite loss as a potential preclinical AD biomarker, and WM microstructure associated with reduced AD risk.